The stock market just had a banner year. To elaborate, more than 400 U.S. companies went public in 2021, but many investors ...

Quadrant Future Tek’s IPO opened on January 7, aiming to raise ₹290 crore. It was 41.41 times subscribed by Day 2, with a ...

Dr. Agarwal’s, Casagrand Premier and Regreen Excel EPC are among the companies which received approval from the markets ...

Aker ASA's NAV discount persists, with concerns about oil market dynamics and Cognite's cash burn affecting value realization ...

The IPO’s upper price band is at ₹52. The ₹25.12 crore IPO closed on January 3, 2025, oversubscribed 182 times. The company ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

As 2025 begins, the U.S. IPO market is starting slowly. Nevertheless, the market is rife with news of popular names like ...

Although 2024 was an exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025. In ...

Through its investment banking division, EFG Hermes acted as a joint bookrunner and underwriter on the transaction ...

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

The allotment status will be released online on the registrar website. Standard Glass Lining IPO registrar is Kfin ...

Dr Agarwal's Health Care, Casagrand Premier, Highway Infrastructure and Regreen-Excel EPC have received markets regulator Sebi's go ahead to raise funds through an IPO. In Sebi's parlance, observation ...